LOS ANGELES, Sept. 10, 2018 /PRNewswire/ -- LA BioMed invites media to their fifth annualInnovation Showcase on September 13th at westdrift in Manhattan Beach, CA. The Showcase will highlight some of biotechnology's most promising start-ups and venture capital leaders.
Leading Venture Capitalist will reveal growing trends and method for choosing which venture to support:
Finally, a key trend will be highlighted in this showcase which attending media will have exclusive access to: Investors know that superbugs are a more dangerous threat than ever before and VC's are eager to identify leading scientific ingenuity targeted at averting potential global epidemics.
Registration details, biographies on presenting companies, and an agenda can be found on the Innovation Showcase homepage.
Where: westdrift Manhattan Beach, Autograph Collection 1400 Parkview Avenue Manhattan Beach, CA 90266
When: Thursday,September 13, 2018 at 9 a.m.
Who: 32 – Presenting companies; 15 – BioTech, VC and Industry Speakers; 250– Participants.
David Meyer , PhD, President and CEO, LA BioMed; Keith Hoffman, PhD, Vice President of Business Development and Technology Transfer, LA BioMed; Kevin Kinsella, Founding Partner at Avalon Ventures; Camille Samuels, Partner at Venrock; and biotech startup leaders
How to Attend: Press may e-mail Kevin Byrum at firstname.lastname@example.org and Erin Bzymek at email@example.com to attend.
About LA BioMed LA BioMed is an incubator of innovation with a global reach and a 66-year reputation of improving and saving lives. Driven by the positive social impacts of breakthrough therapies, the Southern California-based research institute and incubator – with over 100 principal investigators (PhDs, MDs and MD/PhDs) working on over 600 research studies, including therapies for multiple orphan diseases – is an essential element to one of the nation's top-ten biotech clusters. Find out more at https://labiomed.org.
View original content:http://www.prnewswire.com/news-releases/media-advisory-promising-biotech-start-ups--venture-capital-leaders-convene-sept-13-in-manhattan-beach--la-biomeds-5th-annual-innovation-showcase-300709791.html
SOURCE LA BioMed
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All